Moderna, Inc. 

MRNA Price

What is Moderna, Inc. (MRNA)?

Moderna, Inc. is a NASDAQ-listed biotechnology company (ticker MRNA) that develops messenger RNA medicines and vaccines. DropsTab tracks crypto-market exposure to Moderna equity — a spot tokenized stock (RMRNA on Bitget) and equity-referencing perpetual futures on major venues. Moderna issues no native crypto token; every instrument on this page is a wrapper or derivative on the underlying share. Moderna has traded on NASDAQ since its December 2018 IPO, priced at $23/share.

What does Moderna do?

Moderna develops messenger RNA (mRNA) medicines — vaccines and therapies that instruct cells to produce disease-specific proteins. The Moderna platform gained global prominence with the Spikevax COVID-19 vaccine. The current pipeline spans respiratory vaccines, individualized cancer vaccines, and rare-disease therapies. Moderna was founded in 2010 and is headquartered in Cambridge, Massachusetts.

Can you invest in Moderna via crypto?

Yes — through tokenized stock, not direct share ownership. The only spot instrument is RMRNA/USDT on Bitget, a wrapper pegged 1:1 to the underlying MRNA share. Crypto traders can also access MRNA through equity-referencing perpetual futures. Tokenized equities fall under securities regulation and are not available in all jurisdictions — availability on a venue does not imply legality for every user.

What is RMRNA and what backs its value?

RMRNA is a Reality Protocol rToken — the R-prefix ticker convention used on Bitget. Reality Protocol issues each RMRNA token 1:1 against one MRNA share held in custody by a registered U.S. securities broker. The wrapper trades against USDT, including weekend hours when NASDAQ is closed. Wrapper supply on secondary venues is not publicly disclosed.

Where does Moderna crypto exposure trade — RMRNA/USDT spot or perpetuals?

Per DropsTab data, spot exposure to Moderna runs through the Bitget RMRNA/USDT wrapper, alongside equity-referencing perpetual futures on Hyperliquid, OKX, Bybit, Gate.io, and Bitunix. No DEX market exists for RMRNA. Perpetuals dominate the exposure and add leverage plus funding-rate costs, while spot access runs through the Bitget wrapper.

Is a Moderna perpetual the same as owning the tokenized stock?

No. RMRNA tokens are claims on real shares held in broker custody. MRNA perpetual futures are leveraged derivatives that reference the share price, charge funding rates, and confer no ownership of the underlying equity. Bitget launched MRNA stock perpetuals in August 2026 with up to 20x leverage, trading 24/7.

Why did Moderna stock move sharply in 2026?

In August 2026, the Phase 3 INTerpath-001 trial of intismeran autogene — Moderna's individualized cancer vaccine co-developed with Merck — met its primary endpoints. The Keytruda combination showed a 49% reduction in risk of recurrence or death (HR 0.51) and a 62% reduction in distant-metastasis risk versus Keytruda alone in resected high-risk melanoma. The readout was a major equity catalyst for Moderna.

Is Moderna a coin or a tokenized stock?

Moderna is a tokenized stock — a TradFi equity tracker, not a coin or native crypto token. The MRNA tracking surface has no native token, no on-chain contract, and no protocol emission. DropsTab classifies Moderna under TradFi. The nearest supply analogue is the equity's roughly 385 million shares outstanding per company filings.